Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

Vandana Mehta, C. Balachandran

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

Original languageEnglish
Pages (from-to)140-141
Number of pages2
JournalIndian Journal of Dermatology
Volume53
Issue number3
Publication statusPublished - 01-07-2008
Externally publishedYes

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this